InnoTherapy Inc Asset Resilience Ratio

Latest as of September 2025: 4.79%

InnoTherapy Inc asset resilience ratio. InnoTherapy Inc (246960) has an Asset Resilience Ratio of 4.79% as of September 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See InnoTherapy Inc (246960) liquidity interval to measure how many days the company can operate on defensive assets alone.

Liquid Assets

₩3.61 Billion
≈ $2.45 Million USD Cash + Short-term Investments

Total Assets

₩75.35 Billion
≈ $51.06 Million USD All company assets

Resilience Assessment

Low
Financial Resilience Level

Asset Resilience Ratio of InnoTherapy Inc (2015–2024)

Asset resilience ratio of InnoTherapy Inc from 2015 to 2024. This chart shows how InnoTherapy Inc's Asset Resilience Ratio has changed over time. Read 246960 total liabilities for a breakdown of total debt and financial obligations.

Liquid Assets Composition Over Time

This chart breaks down InnoTherapy Inc's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For the complete balance sheet picture, see 246960 asset base.

Current Liquid Assets Breakdown

Component Amount % of Total Assets
Cash & Equivalents ₩0.00 0%
Short-term Investments ₩3.61 Billion 4.79%
Total Liquid Assets ₩3.61 Billion 4.79%

Asset Resilience Insights

  • Limited Liquidity: InnoTherapy Inc maintains only 4.79% of assets in liquid form.
  • This low level may indicate efficient asset utilization but could pose risks during economic downturns.
  • The company has significant short-term investments, indicating active treasury management.

InnoTherapy Inc Industry Peers by Asset Resilience Ratio

Compare InnoTherapy Inc's asset resilience ratio with other companies in the same industry.

Company Industry Asset Resilience Ratio
HOB Biotech Group Corp Ltd
SHG:688656
Medical Devices 2.62%
L&C Bio Co. Ltd
KQ:290650
Medical Devices 2.14%
Applied BioCode
TW:6598
Medical Devices 9.75%
Oncosil Medical Ltd
AU:OSL
Medical Devices 0.00%
Cleo Diagnostics Ltd
AU:COV
Medical Devices 94.64%
Radiant Innovation
TWO:3373
Medical Devices 0.82%
Impedimed Ltd
AU:IPD
Medical Devices 46.15%
Memphasys Ltd
AU:MEM
Medical Devices 0.00%

InnoTherapy Inc Asset Resilience Ratio by Year (2015–2024)

InnoTherapy Inc asset resilience ratio by year from 2015 to 2024. The table below shows the annual Asset Resilience Ratio data for InnoTherapy Inc.

Year Asset Resilience Ratio (%) Liquid Assets Total Assets Change
2024-12-31 4.63% ₩1.11 Billion
≈ $754.66K
₩24.06 Billion
≈ $16.30 Million
-24.49pp
2023-12-31 29.12% ₩8.78 Billion
≈ $5.95 Million
₩30.16 Billion
≈ $20.44 Million
+16.48pp
2022-12-31 12.64% ₩3.89 Billion
≈ $2.64 Million
₩30.81 Billion
≈ $20.88 Million
-20.05pp
2021-12-31 32.68% ₩10.42 Billion
≈ $7.06 Million
₩31.88 Billion
≈ $21.61 Million
+5.95pp
2020-12-31 26.73% ₩4.64 Billion
≈ $3.14 Million
₩17.35 Billion
≈ $11.76 Million
-35.67pp
2019-12-31 62.40% ₩10.75 Billion
≈ $7.29 Million
₩17.23 Billion
≈ $11.68 Million
+32.50pp
2018-12-31 29.90% ₩3.34 Billion
≈ $2.26 Million
₩11.18 Billion
≈ $7.57 Million
+24.62pp
2017-12-31 5.28% ₩222.05 Million
≈ $150.48K
₩4.20 Billion
≈ $2.85 Million
-24.25pp
2016-12-31 29.53% ₩2.08 Billion
≈ $1.41 Million
₩7.03 Billion
≈ $4.77 Million
+3.29pp
2015-12-31 26.24% ₩2.13 Billion
≈ $1.44 Million
₩8.11 Billion
≈ $5.50 Million
--
pp = percentage points

About InnoTherapy Inc

KQ:246960 Korea Medical Devices
Market Cap
$12.06 Million
₩17.79 Billion KRW
Market Cap Rank
#26422 Global
#1991 in Korea
Share Price
₩2095.00
Change (1 day)
+3.46%
52-Week Range
₩1440.00 - ₩2875.00
All Time High
₩25350.00
About

SCL Science Inc. produces medical hemostatic agents using biomimetic technology. Its products include BiMM (Bio-inspired Medical Materials) that reacts immediately with blood; Endoseal, which is used for specialized indication of gastrointestinal bleeding; InnoSeal, a hemostatic agent that is used in various surgical fields, such as cardiology, radiology, and neurosurgery; Jelly Seal, a hemostasi… Read more